SRI 37892
SRI 37892 is a potent small-molecule inhibitor targeting Frizzled-7 (Fzd7), effectively suppressing canonical Wnt/β-catenin signaling. This activity reduces cancer cell viability, making it a valuable tool for in vitro and in vivo research in oncology, particularly for studying Wnt-driven cancers.
Product Specifications
CAS Number
1030769-75-5
Product Name Alternative
FZD7, bcatenin, betacatenin, beta-catenin, Wnt, Wnt/betacatenin, Wnt/b-catenin, Wnt/β-catenin, βcatenin, SRI37892, SRI-37892, SRI 37892
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Purity
98.92% (May vary between batches)
Solubility
DMSO:50 mg/mL (107.4 mM)
Smiles
C (NC1=NC (=CS1) C=2C=C3C (=CC2) NC (=O) CC3) (=O) C4=CC=C (N5C=6C (N=C5) =CC=CC6) C=C4
Molecular Formula
C26H19N5O2S
Molecular Weight
465.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C8929-03F-Biotin 200 µL
CYP24A1, CT (1,25-dihydroxyvitamin D (3) 24-hydroxylase, Mitochondrial, Vitamin D (3) 24-hydroxylase, 24-OHase, Cytochrome P450 24A1, Cytochrome P450-CC24, CYP24) (Biotin) discontinued
Sign In for Pricing
View Details 
PX-TA2059-01 50 µg
Denecimig Biosimilar - Anti-F9 and F10 mAb - Research Grade
Sign In for Pricing
View Details PX-TA2059-02 100 µg
Denecimig Biosimilar - Anti-F9 and F10 mAb - Research Grade
Sign In for Pricing
View Details PX-TA2059-03 1 mg
Denecimig Biosimilar - Anti-F9 and F10 mAb - Research Grade
Sign In for Pricing
View Details